Добавил:
shahzodbeknormurodov27@gmail.com Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Oxford American Handbook of Urology ( PDFDrive ).pdf
Скачиваний:
12
Добавлен:
27.08.2022
Размер:
4.57 Mб
Скачать

Chapter 14

531

 

 

Urological problems in pregnancy

Physiological and anatomical changes in the urinary tract 532 Urinary tract infection (UTI) 534

Hydronephrosis 536

532 CHAPTER 14 Urological problems in pregnancy

Physiological and anatomical changes in the urinary tract

Kidney

Renal size enlarges by 1 cm, secondary to increased interstitial volume and increased renal vasculature.

Renal plasma flow rate (RPF) increases early in the first trimester (up to 75% by term).

Glomerular filtration rate (GFR) increases by 50%, related to an increased cardiac output.

Renal function and biochemical parameters are affected by changes in RPF and GFR. Creatinine clearance increases, and serum levels of creatinine, urea, and urate fall in normal pregnancy (see Table 15.1). Raised GFR causes an increased glucose load at the renal tubules and results in glucose excretion (glycosuria) in most pregnancies. 24-hour protein excretion remains unchanged. Urine output increases.

Salt and water handling: A reduction in serum sodium causes reduced plasma osmolality. The kidney compensates by increasing renal tubular reabsorption of sodium. Plasma renin activity is increased 10-fold,

and levels of angiotensinogen and angiotensin are increased 5-fold. Osmotic thresholds for antidiuretic hormone (ADH) and thirst decrease.

Acid–base metabolism Serum bicarbonate is reduced. Increased progesterone stimulates the respiratory center resulting in reduced PCO2.

Bladder

Bladder displacement occurs (superiorly and anteriorly) due to the enlarging uterus. The bladder becomes hyperemic, and raised estrogen levels cause hyperplasia of muscle and connective tissues.

Bladder pressures can increase over pregnancy (from 8 to 20 cmH2O), with associated rises in absolute and functional urethral length and pressures.

Lower urinary tract symptoms: Urinary frequency (>7 voids during the day) and nocturia (>1 void at night) increases over the duration of gestation (incidence of 80–90% in third trimester). Urgency and urge

incontinence also increase secondary to pressure effects from the enlarging uterus.

Stress urinary incontinence occurs in 22%, and increases with parity (pregnancies that result in delivery beyond 28 weeks’ gestation). It is partly caused by placental production of peptide hormones (relaxin), which induces collagen remodeling and consequent softening of tissues of the birth canal. Infant weight, duration of first and second stages of labor (vaginal delivery), and instrumental delivery (ventouse extraction or forceps delivery) increase risks of postpartum (after delivery of the child) stress incontinence.

PHYSIOLOGICAL AND ANATOMICAL CHANGES 533

Table 14.1 Biochemistry reference intervals

Substance

Nonpregnant

Pregnant

 

 

Sodium (mmol/L)

135–145

132–141

 

Urea (mmol/L)

2.5–6.7

2.0–4.2

 

Urate (µmol/L)

150–390

100–270

 

Creatinine (µmol/L)

70–150

24–68

 

Creatinine clearance (mL/min)

90–110

150–200

 

Bicarbonate (mmol/L)

24–30

20–25

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

534 CHAPTER 14 Urological problems in pregnancy

Urinary tract infection (UTI)

Definition

UTI describes a bacterial infection of the urine with >105 colony forming units (CFU)/mL (or >102 CFU/mL if the patient is systemically unwell).

Incidence

Pregnancy does not alter the incidence of UTI, which remains at 4% for women of reproductive age. However, physiological and anatomical changes associated with pregnancy alter the course of infection, causing an increased risk of recurrent UTI and progression to acute pyelonephritis (up to 28%).

Risk factors

These include previous history of recurrent UTIs and pre-existing vesicoureteric reflux. Physiological changes in pregnancy include hydronephrosis with decreased ureteral peristalsis causing urinary stasis. Up to 75% of pyelonephritis cases occur in the third trimester, when these changes are most prominent.

Pathogenesis

A common causative organism is Escherichia coli. An increased risk of gestational pyelonephritis is associated with E. coli containing the virulence factor Dr adhesin.

Complications

UTI increases the risk of preterm delivery, low fetal birth weight, and maternal anemia.

Screening tests

Midstream urine specimen (MSU)

MSU should be obtained at the first antenatal visit and sent for urinalysis and culture to look for bacteria, protein, and blood. A second MSU investigation is recommended at later visits (week 16) to examine for bacteria, protein, and glucose.

Treatment

All proven episodes of UTI should be treated (asymptomatic or symptomatic), guided by urine culture sensitivities. Antibiotics that are safe to use during pregnancy include penicillins (i.e., ampicillin, amoxicillin, penicillin V) and cephalosporins (i.e., cefaclor, cefalexin, cefotaxime, ceftriaxone, cefuroxime). Nitrofurantoin may be used in first and second trimesters only. See Table 14.2 for antibiotics that are not safe to use.

Repeat urine cultures after treatment to check that bacteria have been eliminated.

Acute pyelonephritis requires hospital admission for intravenous antibiotics (cephalosporin or aminopenicillin) until apyrexial, followed by oral antibiotics for 14 days, and repeated cultures for the duration of pregnancy.

 

 

 

URINARY TRACT INFECTION (UTI)

535

 

Table 14.2 Antibiotics to avoid in pregnancy*

 

 

 

 

 

 

 

 

Trimester

Antibiotic

Risk in pregnancy

 

 

 

 

 

 

 

1,2,3

Tetracyclines

Fetal malformation; maternal

 

 

 

 

hepatotoxicity; dental discoloration

 

 

 

Quinolones

Arthropathy

 

1

Trimethoprim

Teratogenic risk (folate antagonist)

 

2,3

Aminoglycosides

Auditory or vestibular nerve damage

 

3

Chloramphenicol

Neonatal gray syndrome

 

 

 

Sulfonamides

Neonatal hemolysis; methemoglobinemia

 

 

 

Nitrofurantoin

Maternal or neonatal hemolysis (if used at

 

 

 

 

term), in subjects with G6PD deficiency

 

 

 

 

 

 

 

* See Krieger JN (1986). Complications and treatment of urinary tract infection during pregnancy. Urol Clin North Am 13:685.